SAGE THERAPEUTICS INC (SAGE)
US78667J1088 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.3M -99.43% | 7.7M 22.22% | 86.455M 1,022.79% | 43.169M -50.07% | 96.119M 122.66% | 161.17M 67.68% | 203.9M 26.51% | 290.36M 42.40% | 438.51M 51.02% | 514.25M 17.27% | 594.07M 15.52% | |
| EBITDA YoY % growth | -456.7M -172.90% | -545.9M -19.53% | -545.07M 0.15% | -420.862M 22.79% | -284.606M 32.38% | -205.79M 27.69% | -124.44M 39.53% | -65.688M 47.21% | N/A | N/A | N/A | |
| EBIT YoY % growth | -460.9M -173.87% | -547M -18.68% | -546.463M 0.10% | -429.57M 21.39% | -263.703M 38.61% | -222.028M 15.80% | -131.542M 40.75% | -33.666M 74.41% | 81.088M 340.86% | 132.05M 62.85% | 188.83M 43.00% | |
| Operating Margin | -7,315.87% | -7,103.90% | -632.08% | -995.09% | -274.35% | -137.76% | -64.51% | -11.59% | 18.49% | 25.68% | 31.79% | |
| EPS YoY % growth | -7.80 -167.01% | -8.98 -15.13% | -10.31 -14.81% | -6.70 34.99% | -3.98 40.62% | -2.89 27.42% | -2.03 29.57% | -0.59 70.92% | 2.18 468.67% | 3.38 55.18% | 3.24 -4.17% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.59 11.79% | -1.30 27.75% | -1.23 27.85% | -1.17 23.81% | -1.12 29.34% | -1.06 18.43% | -1.03 16.01% | -0.98 16.00% | -0.60 46.36% |
| Revenue Q2Q % growth | 14.413M -81.52% | 16.312M 106.43% | 18.342M 111.95% | 20.415M 71.97% | 23.201M 60.97% | 32.13M 96.97% | 37.903M 106.65% | 45.492M 122.84% | 74.154M 219.62% |
| EBITDA Q2Q % growth | -101.872M -149.11% | -82.006M 30.11% | -75.877M 31.43% | -75.919M 24.31% | -75.094M 26.29% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -100.541M -137.76% | -84.369M 28.30% | -80.827M 27.38% | -79.571M 21.37% | -78.077M 22.34% | -71.029M 15.81% | -69.102M 14.51% | -65.614M 17.54% | -42.012M 46.19% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.53 54.60% | -1.56 | 0.03 | 2.18% |
| Q2 2024 Q2Q % growth | -1.70 36.57% | -1.69 | -0.01 | -0.48% |
| Q1 2024 Q2Q % growth | -1.80 26.83% | -1.68 | -0.12 | -7.14% |
| Q4 2023 Q2Q % growth | -1.80 27.13% | -1.30 | -0.50 | -38.16% |
| Q3 2023 Q2Q % growth | -3.37 -45.89% | -2.79 | -0.58 | -21.00% |
| Q2 2023 Q2Q % growth | -2.68 -25.82% | -2.60 | -0.08 | -2.89% |
| Q1 2023 Q2Q % growth | -2.46 -18.84% | -2.55 | 0.09 | 3.37% |
| Q4 2022 Q2Q % growth | -2.47 -16.51% | -2.44 | -0.03 | -1.43% |
| Q3 2022 Q2Q % growth | -2.31 -4.52% | -2.25 | -0.06 | -2.60% |
| Q2 2022 Q2Q % growth | -2.13 -16.39% | -2.20 | 0.07 | 2.98% |
| Q1 2022 Q2Q % growth | -2.07 -26.22% | -2.08 | 0.01 | 0.35% |
| Q4 2021 Q2Q % growth | -2.12 -111.65% | -2.21 | 0.09 | 4.29% |
| Q3 2021 Q2Q % growth | -2.21 -8.87% | -1.89 | -0.32 | -16.91% |
| Q2 2021 Q2Q % growth | -1.83 12.02% | -1.73 | -0.10 | -5.95% |
| Q1 2021 Q2Q % growth | -1.64 32.79% | -1.95 | 0.31 | 15.77% |
| Q4 2020 Q2Q % growth | 18.19 659.69% | -0.36 | 18.55 | 5,163.12% |
| Q3 2020 Q2Q % growth | -2.03 41.67% | -2.43 | 0.40 | 16.61% |
| Q2 2020 Q2Q % growth | -2.08 36.59% | -2.71 | 0.63 | 23.32% |
| Q1 2020 Q2Q % growth | -2.44 27.60% | -3.20 | 0.76 | 23.77% |
| Q4 2019 Q2Q % growth | -3.25 3.85% | -3.68 | 0.43 | 11.63% |
| Q3 2019 Q2Q % growth | -3.48 -32.32% | -3.43 | -0.05 | -1.41% |
| Q2 2019 Q2Q % growth | -3.28 -811.11% | -3.40 | 0.12 | 3.47% |
| Q1 2019 Q2Q % growth | -3.37 -100.60% | -3.31 | -0.06 | -1.71% |
| Q4 2018 Q2Q % growth | -3.38 | -2.98 | -0.40 | -13.57% |
| Q3 2018 Q2Q % growth | -2.63 | -2.46 | -0.17 | -6.77% |
| Q2 2018 Q2Q % growth | -0.36 | -1.93 | 1.57 | 81.30% |
| Q1 2018 Q2Q % growth | -1.68 | -1.88 | 0.20 | 10.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 11.871M 337.08% | 11.018M | 853K | 7.74% |
| Q2 2024 Q2Q % growth | 8.654M 250.36% | 9.025M | -371K | -4.11% |
| Q1 2024 Q2Q % growth | 7.902M 139.89% | 5.891M | 2.011M | 34.14% |
| Q4 2023 Q2Q % growth | 77.972M 2,588.69% | 62.197M | 15.775M | 25.36% |
| Q3 2023 Q2Q % growth | 2.716M 59.76% | 4.71M | -1.994M | -42.34% |
| Q2 2023 Q2Q % growth | 2.47M 64.67% | 3.002M | -532K | -17.72% |
| Q1 2023 Q2Q % growth | 3.294M 105.88% | 2.454M | 840K | 34.23% |
| Q4 2022 Q2Q % growth | 2.9M 81.25% | 1.977M | 923K | 46.69% |
| Q3 2022 Q2Q % growth | 1.7M 21.43% | 1.672M | 28K | 1.67% |
| Q2 2022 Q2Q % growth | 1.5M -6.25% | 1.797M | -297K | -16.53% |
| Q1 2022 Q2Q % growth | 1.6M | 3.271M | -1.671M | -51.09% |
| Q4 2021 Q2Q % growth | 1.6M -99.86% | 2.014M | -414K | -20.56% |
| Q3 2021 Q2Q % growth | 1.4M -12.50% | 1.998M | -598K | -29.93% |
| Q2 2021 Q2Q % growth | 1.6M 45.45% | 2.048M | -448K | -21.88% |
| Q1 2021 Q2Q % growth | 1.6M -30.43% | 2.043M | -443K | -21.68% |
| Q4 2020 Q2Q % growth | 1.109B 55,360.00% | 56.447M | 1.053B | 1,865.03% |
| Q3 2020 Q2Q % growth | 1.6M -55.56% | 1.903M | -303K | -15.92% |
| Q2 2020 Q2Q % growth | 1.1M 22.22% | 905.281K | 194.719K | 21.51% |
| Q1 2020 Q2Q % growth | 2.3M 360.00% | 2.852M | -552K | -19.35% |
| Q4 2019 Q2Q % growth | 2M 566.67% | 3.756M | -1.756M | -46.75% |
| Q3 2019 Q2Q % growth | 3.6M | 3.674M | -74K | -2.01% |
| Q2 2019 Q2Q % growth | 900K -99.00% | 262.364K | 637.636K | 243.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.13% | -1.09% | -0.6% | -0.61% |
| Revenue | 0.35% | 0.57% | -0.16% | 8.95% |